Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

986 ARTÍCULOS , VIENDO DEL 856 AL 870

Linking abnormal neural activity patterns to motor deficits

Herzfeld DJ.

Elife. 2024 Jul 24;13:e100833. doi: 10.7554/eLife.100833.

Molecular therapy for polyQ disorders: from bench to clinical trials

de Sousa-Lourenço J, Silva AC, Pereira de Almeida L, Nobre RJ.

Trends Mol Med. 2024 Sep;30(9):804-808. doi: 10.1016/j.molmed.2024.05.004. Epub 2024 Jun 4.

Consensus Paper: Latent Autoimmune Cerebellar Ataxia (LACA)

Manto M, Hadjivassiliou M, Baizabal-Carvallo JF, Hampe CS, Honnorat J, Joubert B, Mitoma H, Muñiz-Castrillo S, Shaikh AG, Vogrig A.

Cerebellum. 2024 Apr;23(2):838-855. doi: 10.1007/s12311-023-01550-4. Epub 2023 Mar 29.

Spinocerebellar Ataxia in Brazil: A Comprehensive Genotype - Phenotype Analysis

Cunha Ganimi MCD, Couto CM, La Rocque Ferreira A, Antão Paiva CL.

Cerebellum. 2024 Dec;23(6):2414-2425. doi: 10.1007/s12311-024-01745-3. Epub 2024 Sep 25.

[Gastrointestinal disorders in hyperkinetic movement disorders and ataxia]

Claus I, Warnecke T.

Nervenarzt. 2024 Aug;95(8):697-703. doi: 10.1007/s00115-024-01655-z. Epub 2024 Apr 17.

Efficacy and Safety of Repetitive Transcranial Magnetic Stimulation in Cerebellar Ataxia: a Systematic Review and Meta-analysis

Qiu YT, Chen Y, Tan HX, Su W, Guo QF, Gao Q.

Cerebellum. 2024 Feb;23(1):243-254. doi: 10.1007/s12311-022-01508-y. Epub 2023 Jan 6.

Clinical and genetic spectrum of RNF216-related disorder: a new case and literature review

Wu C, Zhang Z.

J Med Genet. 2024 Apr 19;61(5):430-434. doi: 10.1136/jmg-2023-109397.

Rhombencephalosynapsis: A Rare Hindbrain Malformation

Khaladkar SM, Jhala NA, Shukla A, Shah R, Durgi EC.

Cureus. 2024 Jul 26;16(7):e65400. doi: 10.7759/cureus.65400. eCollection 2024 Jul.

Recent advances in diagnosis of immune-mediated cerebellar ataxias: novel concepts and fundamental questions on autoimmune mechanisms

Mitoma H, Manto M.

J Neurol. 2024 Oct;271(10):7046-7053. doi: 10.1007/s00415-024-12596-7. Epub 2024 Jul 25.

ACR Appropriateness Criteria® Dizziness and Ataxia: 2023 Update

Expert Panel on Neurological Imaging; Wang LL, Thompson TA, Shih RY, Ajam AA, Bulsara K, Burns J, Davis MA, Ivanidze J, Kalnins A, Kuo PH, Ledbetter LN, Pannell JS, Pollock JM, Shakkottai VG, Shih RD, Soares BP, Soderlund KA, Utukuri PS, Woolsey S, Policeni B.

J Am Coll Radiol. 2024 Jun;21(6S):S100-S125. doi: 10.1016/j.jacr.2024.02.018.

Optimizing Communication in Ataxia: A Multifaceted Approach to Alternative and Augmentative Communication (AAC)

Vogel AP, Spencer C, Burke K, de Bruyn D, Gibilisco P, Blackman S, Vojtech JM, Kathiresan T.

Cerebellum. 2024 Oct;23(5):2142-2151. doi: 10.1007/s12311-024-01675-0. Epub 2024 Mar 7.

Consensus Recommendations for Clinical Outcome Assessments and Registry Development in Ataxias: Ataxia Global Initiative (AGI) Working Group Expert Guidance

Klockgether T, Synofzik M; AGI working group on COAs and Registries.

Cerebellum. 2024 Jun;23(3):924-930. doi: 10.1007/s12311-023-01547-z. Epub 2023 Apr 5.

Potential Benefit of Channel Activators in Loss-of-Function Primary Potassium Channelopathies Causing Heredoataxia

Gazulla J, Berciano J.

Cerebellum. 2024 Apr;23(2):833-837. doi: 10.1007/s12311-023-01584-8. Epub 2023 Jul 17.

An overview of early-onset cerebellar ataxia: a practical guideline

Hosseinpour S, Bemanalizadeh M, Mohammadi P, Ashrafi MR, Heidari M.

Acta Neurol Belg. 2024 Dec;124(6):1791-1804. doi: 10.1007/s13760-024-02595-w. Epub 2024 Jul 1.

Potential Clinical Benefit of Very Long Chain Fatty Acid Supplementation in Spinocerebellar Ataxia Type 34

Gazulla J, Berciano J.

Cerebellum. 2024 Oct;23(5):2193-2196. doi: 10.1007/s12311-024-01705-x. Epub 2024 May 21.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias